A global IT and professional services company, Cognizant helps organizations modernize their technology and adopt artificial intelligence, offering consulting, software development, and business process services across industries like health, finance, and retail. It began in 1994 in Chennai, India, as an in-house tech unit of Dun & Bradstreet before spinning off in 1996 and taking a name drawn from the Latin "cognoscere," meaning "to get to know." One of the world's largest IT services firms, it keeps a workforce of roughly three hundred fifty thousand people, most based in India, under its global delivery model.
Cognizant reports Q2 2026 revenue of $5.5B, up 4.5% YoY; raises full-year EPS guidance
Q2 2026 revenue was $5.481 billion, up 4.5% year-over-year (4.1% in constant currency).
Show detailsHide details
GAAP operating margin was 15.9%, up 30 bps YoY; adjusted operating margin was 16.0%, up 40 bps YoY.
GAAP diluted EPS was $1.36, up 3.8% YoY; adjusted diluted EPS was $1.37, up 4.6% YoY.
Full-year 2026 guidance: constant currency revenue growth of 4.0% to 5.5%, adjusted operating margin of 16.0% to 16.2%, and adjusted diluted EPS of $5.70 to $5.82.
Q2 2026 share repurchases totaled $1.153 billion; quarterly dividend of $0.33 per share declared.
2.02 Results of Operations and Financial Condition · 7.01 Regulation FD Disclosure · 9.01 Financial Statements and Exhibits
Cognizant discloses preliminary approval of derivative suit settlement
On June 30, 2026, the U.S. District Court for the District of New Jersey preliminarily approved a proposed settlement of the stockholder derivative action Palempalli v. Patsalos-Fox, et al.
Show detailsHide details
The settlement, dated November 25, 2025, resolves claims of breach of fiduciary duty, waste, unjust enrichment, and securities law violations related to alleged FCPA violations and share repurchases.
A final settlement hearing is scheduled for September 14, 2026, before Judge Stacey D. Adams in Newark, New Jersey.
The settlement provides for a payment to Cognizant by its directors and officers insurance carriers; no claims procedure for stockholders is included.
Cognizant filed the Long-Form Notice and Stipulation of Settlement as exhibits to this Form 8-K under Item 7.01 Regulation FD.
7.01 Regulation FD Disclosure · 9.01 Financial Statements and Exhibits
Cognizant raises 2026 share repurchase target by $1B to $2B, board adds $2B authorization
On May 17, 2026, Cognizant's Board approved a $2 billion increase to its existing stock repurchase program, leaving approximately $3.45 billion remaining under the authorization as of that date.
Show detailsHide details
The company increased its 2026 share repurchase expectation by $1 billion to $2 billion, with the additional $1 billion expected to be completed in Q2 2026.
Cognizant will draw down $1 billion from its existing revolving credit facility to fund the repurchases, in connection with the anticipated closing of its previously announced acquisition of Astreya.
CEO Ravi Kumar S stated the increase reflects conviction in AI opportunities and belief that the current share price undervalues the company's prospects.
The report was filed under Item 7.01 Regulation FD Disclosure, with the press release attached as Exhibit 99.1, and is not deemed 'filed' for SEC liability purposes.
7.01 Regulation FD Disclosure · 9.01 Financial Statements and Exhibits
Cognizant reports Q4 2025 revenue of $5.3B, up 4.9% YoY; full-year revenue $21.1B, up 7.0%
Fourth quarter 2025 revenue was $5.333 billion, up 4.9% year-over-year (3.8% in constant currency).
Show detailsHide details
Full-year 2025 revenue was $21.108 billion, up 7.0% year-over-year (6.4% in constant currency).
Full-year 2025 GAAP diluted EPS was $4.56, up 1% year-over-year; adjusted diluted EPS was $5.28, up 11%.
Full-year 2025 adjusted operating margin was 15.8%, up 50 basis points year-over-year.
2026 guidance: constant currency revenue growth of 4.0% to 6.5%, adjusted operating margin of 15.9% to 16.1%, and adjusted diluted EPS of $5.56 to $5.70.
2.02 Results of Operations and Financial Condition · 7.01 Regulation FD Disclosure · 9.01 Financial Statements and Exhibits